Following National Advertising Division Challenge, NutriDrip Voluntarily Modified or Discontinued Certain NutrIMMUNITY IV Drip Therapy Claims
New York, NY – May 30, 2024 – Following a challenge brought by BBB National Programs’ National Advertising Division as part of its routine monitoring program, NutriDrip/JMB Medical Group, PLLC discontinued certain advertising claims used to promote its NutrIMMUNITY IV Drip Therapy.
NutriDrip offers intravenous nutritional therapy treatment via fluids, electrolytes, vitamins, and minerals to deliver nutrients to the body.
The National Advertising Division (NAD) challenged a number of health-related claims, including claims that the Drip Therapy boosts immune defenses. NAD also challenged a testimonial relating to the efficacy of the drip therapy.
NutriDrip objected to NAD’s jurisdiction on the grounds that its advertising is not “national advertising” as it is only directed to consumers in New York City and Las Vegas where its clinics are located. However, NAD determined that it has jurisdiction over the challenged claims because NutriDrip’s website is accessible from anywhere and NutriDrip’s advertising targets travelers, a national audience, for NutriDrip locations in or near hotels in both cities.
NutriDrip informed NAD that it is permanently discontinuing or modifying the challenged claims. Therefore, NAD did not review the claims on their merits and will treat the claims, for compliance purposes, as though NAD recommended their discontinuance or modification.
In its advertiser statement, NutriDrip stated that it “agrees to comply and thanks NAD for its consideration.”
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB procedures, this release shall not be used for advertising or promotional purposes.
Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.
Latest Decisions
Following National Advertising Division Inquiry, Google Voluntarily Unlists Video Demonstrating Google Gemini Capabilities
New York, NY – September 12, 2024 – Google voluntarily unlisted a video demonstrating the capabilities of Google Gemini, its large language model artificial intelligence (AI) offering introduced in December 2023.
National Advertising Division Recommends Gruma Modify Sugar and Net Carbohydrate Label Claims
New York, NY – September 11, 2024 – In a challenge brought by competitor Olé, the National Advertising Division found certain “zero sugar” and “0G sugar” claims supported and recommended that Gruma Corporation, in connection with its tortilla product offerings, modify or discontinue other claims.
Direct Selling Self-Regulatory Council Recommends MONAT Discontinue Earnings Claims
McLean, VA – September 5, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended MONAT Global discontinue certain earnings claims made on the MONAT website and by salesforce members on Facebook, Twitter/X, Instagram, and YouTube.
National Advertising Division Refers HiSmile Teeth Whitening Product Claims to the Federal Trade Commission